ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
32 hedge funds and large institutions have $14.7M invested in Acorda Therapeutics in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Holders
32
Holding in Top 10
–
Calls
$898K
Puts
$491K
Top Buyers
| 1 | +$186K | |
| 2 | +$179K | |
| 3 | +$109K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$88.2K |
| 5 |
AWM
Apollon Wealth Management
Mount Pleasant,
South Carolina
|
+$69K |
Top Sellers
| 1 | -$1.94M | |
| 2 | -$645K | |
| 3 | -$235K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$213K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$164K |